NCT02836431View on ClinicalTrials.gov

Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2018

Conditions
Heart Disease
Interventions
DRUG

Dexmedetomidine 1mcg/kg Intranasal

DEX 1 mcg/kg Intranasal

DRUG

Dexmedetomidine 2mcg/kg Intranasal

DEX 2 mcg/kg Intranasal

DRUG

Dexmedetomidine 1mcg Intravenous

DEX 1 mcg/kg Intravenously

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02836431 - Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children | Biotech Hunter | Biotech Hunter